Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3675062016 | Pentazocine (as pentazocine lactate) 50 mg rectal suppository | en | Synonym | Active | Case insensitive | SNOMED CT core |
3675063014 | Product containing precisely pentazocine (as pentazocine lactate) 50 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Is a | Pentazocine only product in rectal dose form | true | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Is a | Pentazocine-containing product | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has active ingredient | Opiate agonist-antagonist | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has active ingredient | Pentazocine | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has active ingredient | Central nervous system agent | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Is a | Pentazocine-containing product in rectal dose form | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has manufactured dose form | Rectal dose form | false | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has manufactured dose form | Rectal suppository | true | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has precise active ingredient | Pentazocine lactate | true | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has BoSS | Pentazocine | true | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has presentation strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has unit of presentation | Suppository | true | Inferred relationship | Some | ||
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Pentazocine (as pentazocine lactate) 50 mg rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets